P3 Health Partners Stock In The News

PIII Stock  USD 0.17  0.01  5.56%   
Our overall analysis of P3 Health's news coverage and content from conventional and social sources shows investors' bearish mood towards P3 Health Partners. The specific impact of P3 Health news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of P3 Health's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using P3 Health headlines in addition to utilizing other, more conventional financial analysis modules. Check out P3 Health Backtesting and P3 Health Hype Analysis.

P3 Health Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
https://www.globenewswire.com/news-release/2025/02/10/3023841/0/en/Kuehn-Law-Encourages-Investors-of-P3-Health-Partners-Inc-to-Contact-Law-Firm.html
 Neutral
Yahoo News
10 Best High Short Interest Stocks to Buy Now
https://finance.yahoo.com/news/10-best-high-short-interest-141003147.html
 Bullish
Macroaxis News: globenewswire.com
P3 Health Partners Provides Second-Quarter and Year-to-Date 2022 Financial Results; Increases 2022 Revenue Outlook
https://www.globenewswire.com/news-release/2022/10/20/2538839/0/en/P3-Health-Partners-Provides-Second-Quarter-and-Year-to-Date-2022-Financial-Results-Increases-2022-Revenue-Outlook.html
 Neutral
Macroaxis News: globenewswire.com
P3 Health Partners Announces Chief Financial Officer Transition Appoints Erin Darakjian as Interim CFO
https://www.globenewswire.com/news-release/2022/10/20/2538818/0/en/P3-Health-Partners-Announces-Chief-Financial-Officer-Transition-Appoints-Erin-Darakjian-as-Interim-CFO.html
 Bullish
Macroaxis News: globenewswire.com
P3 Health Partners to Present 1H 2022 Financial Results
https://www.globenewswire.com/news-release/2022/10/20/2538371/0/en/P3-Health-Partners-to-Present-1H-2022-Financial-Results.html
 Neutral
Macroaxis News: globenewswire.com
P3 Health Partners Fireside Chat Hosted by LifeSci Advisors, LLC
https://www.globenewswire.com/news-release/2022/08/26/2505413/0/en/P3-Health-Partners-Fireside-Chat-Hosted-by-LifeSci-Advisors-LLC.html
 Bullish
Macroaxis News: globenewswire.com
P3 Health Partners CEO Dr. Sherif Abdou Featured on Benchtop Bios Podcast
https://www.globenewswire.com/news-release/2022/08/22/2502513/0/en/P3-Health-Partners-CEO-Dr-Sherif-Abdou-Featured-on-Benchtop-Bios-Podcast.html
 Bullish
Macroaxis News: globenewswire.com
P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Report
https://www.globenewswire.com/news-release/2022/08/19/2501767/0/en/P3-Health-Partners-Announces-Receipt-of-Nasdaq-Notice-Regarding-Late-Filing-of-Periodic-Report.html
 Neutral
Macroaxis News: globenewswire.com
Oregon State Athletics, P3 Health Partners Oregon Announce Multi-Year Relationship
https://www.globenewswire.com/news-release/2022/07/11/2477219/0/en/Oregon-State-Athletics-P3-Health-Partners-Oregon-Announce-Multi-Year-Relationship.html
 Bullish
Macroaxis News: globenewswire.com
P3 Health Partners Announces Inclusion in the Russell 3000® Index
https://www.globenewswire.com/news-release/2022/06/27/2469527/0/en/P3-Health-Partners-Announces-Inclusion-in-the-Russell-3000-Index.html
 Bullish

P3 Health Partners Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide PIII and other traded companies coverage with news coverage. We help investors stay connected with PIII headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on PIII Stock performance. Please note that trading solely based on the P3 Health Partners hype is not for everyone as timely availability and quick action are needed to avoid losses.
P3 Health's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help P3 Health Partners investors visualize upcoming and past events in order to time the market based on P3 Health Partners noise-free hype analysis.
P3 Health stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the PIII earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about P3 Health that are available to investors today. That information is available publicly through PIII media outlets and privately through word of mouth or via PIII internal channels. However, regardless of the origin, that massive amount of PIII data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of P3 Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of P3 Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to P3 Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive P3 Health alpha.

PIII Largest EPS Surprises

Earnings surprises can significantly impact P3 Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-07
2024-06-30-0.05-0.09-0.0480 
2023-08-07
2023-06-30-0.13-0.090.0430 
2024-05-08
2024-03-31-0.11-0.16-0.0545 
2023-11-08
2023-09-30-0.22-0.120.145 
2024-03-28
2023-12-31-0.11-0.22-0.11100 
2022-04-25
2022-03-31-0.24-0.36-0.1250 
View All Earnings Estimates

P3 Health Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to P3 Health Partners Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
13th of March 2025
Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 90000 shares of P3 Health at 2.523...
at finance.yahoo.com 
zacks News
4th of March 2025
SOPHiA GENETICS SA Reports Q4 Loss, Tops Revenue Estimates
at zacks.com 
Gurufocus Stories at Macroaxis
10th of February 2025
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
at gurufocus.com 
Yahoo News
13th of January 2025
P3 Health Partners to Present at the 43rd Annual J.P. Morgan Healthcare Conference
at finance.yahoo.com 
Investing News at Macroaxis
17th of December 2024
P3 Health Partners secures 25 million financing deal
at investing.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards P3 Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, P3 Health's short interest history, or implied volatility extrapolated from P3 Health options trading.
When determining whether P3 Health Partners is a strong investment it is important to analyze P3 Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact P3 Health's future performance. For an informed investment choice regarding PIII Stock, refer to the following important reports:
Check out P3 Health Backtesting and P3 Health Hype Analysis.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.86)
Revenue Per Share
11.073
Quarterly Revenue Growth
0.256
Return On Assets
(0.18)
Return On Equity
(0.65)
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.